Can't miss stories from the web
Bloomberg reports that JPMorgan Chase & Co.'s claim that traders at its London chief investment office intentionally mismarked trades in order to hide losses of up to $5.8-billion don't add up, according to former executives.
GSK set for Human Genome takeover?
GlaxoSmithKline may announce today a deal to buy Human Genome Sciences for about $2.8-billion (U.S.).
Story continues below advertisement
Roxgold Inc. facing shareholder challenge
A Vancouver-based miner has postponed its scheduled annual shareholder meeting after a dissident slate of directors was submitted.
Canadian del Missier to face U.K. MPs over Libor
The third member of the trio of top bankers ejected from Barclays over the Libor scandal will appear before the U.K.'s Treasury select committee Monday, as MPs aim for a clearer view of the bank's manipulation of interbank borrowing rates.
Glencore gets federal nod for Viterra acquisition bid
The federal government has signed off on Glencore International PLC's bid to acquire Regina-based grain handler Viterra Inc.
New Canadian Pacific chief surveys his new domain
Hunter Harrison is finally getting a closeup view of what used to be enemy territory.